हिंदी में पढ़ें

Lupin

Stocks in Focus on August 28: Lakshmi Vilas Bank, Yes Bank to GHCL; here are the 5 Newsmakers of the Day

Stocks in Focus on August 28: Lakshmi Vilas Bank, Yes Bank to GHCL; here are the 5 Newsmakers of the Day

Wed, Aug 28, 2019

Certain stocks came in news post-market hours yesterday and can have an impact on the market when it reopens today.

Buy or Sell: Stock market experts speak on Bajaj Finance, Lupin and Hexaware stocks

Buy or Sell: Stock market experts speak on Bajaj Finance, Lupin and Hexaware stocks

Thu, Aug 08, 2019

Stock market experts are advising fresh buy in Bajaj Finance futures while they advise investors to avoid fresh buy in Lupin but one can hold the stock who have this stock in their portfolio. In Hexaware, one can buy the stocks for 4-5 per cent gains.

Lupin, M&M to Tata Steel - Which stocks should you buy?

Lupin, M&M to Tata Steel - Which stocks should you buy?

Thu, Aug 08, 2019

Edelweiss said that Lupin’s current valuation of 17.8x FY21E EPS – amid depressed earnings – offers an attractive entry point in its view.

TRENDING NOW

FAST MONEY: SBI, Lupin among top 10 buy and sell ideas for Monday's trade

FAST MONEY: SBI, Lupin among top 10 buy and sell ideas for Monday's trade

Mon, Feb 12, 2018

The domestic market are expected to open higher on Monday, tracking Asian markets, which found a semblance of calm as S&P futures extended their bounce, though bond investors were still fretting about the risks from looming US inflation data.

Lupin's consolidated Q3FY18 PAT drops by 65% yoy; shares touch 52-week low

Lupin's consolidated Q3FY18 PAT drops by 65% yoy; shares touch 52-week low

Tue, Feb 06, 2018

Lupin's consolidated PAT more than halved in Q3FY18 to Rs 221.7 crore, down by 65% from Rs 633.1 crore, in the corresponding period of the previous year.

Lupin launches new antibiotic tablet

Lupin launches new antibiotic tablet

Fri, Jan 19, 2018

The drug is used for the treatment of infections caused by various microorganisms and as an adjunctive therapy in severe acne

Sensex zooms 195 points on strong global cues

Sensex zooms 195 points on strong global cues

Mon, Dec 11, 2017

Benchmark BSE Sensex advanced by 195 points in early session today on continuous buying by domestic institutional investors amid strong global leads. The NSE Nifty also went past the 10,300-mark.

Sensex climbs over 110 points after Asian uptrend

Sensex climbs over 110 points after Asian uptrend

Thu, Aug 24, 2017

dian stocks today shrugged off weakness in US markets as the Sensex surged over 110 points, with domestic investors doing the job amid positive Asian cues.

10 Indian CEOs who took home salaries up to Rs 60 crore in FY17

10 Indian CEOs who took home salaries up to Rs 60 crore in FY17

Mon, Jul 24, 2017

Zeebiz collates and lists salaries of CEO's in India after a report revealed that higher management earned up to 1200 times more than other employees.

Sensex bounces back by 195 points, Nifty rises above 9,600-mark in early trade

Sensex bounces back by 195 points, Nifty rises above 9,600-mark in early trade

Fri, Jun 02, 2017

The key equity indices of Indian markets- Sensex and Nifty- have resumed their record-setting spree and have recovered to fresh lifetime highs in opening trade on Friday on sustained buying amid positive global cues.

Sun Pharma says sales may fall in 2018 as US market gets tougher for generic drugs

Sat, May 27, 2017

Sun Pharmaceutical Industries MD Dilip Shanghvi has said on Friday that the US sales might fall in 2018 because of pressure on drug prices, signalling tough market conditions in the United States (US) for generic drugmakers.

Earnings, global cues to set trend this week; stocks may see volatility

Earnings, global cues to set trend this week; stocks may see volatility

Sun, May 21, 2017

Indian stock markets this week are likely to witness volatility in the midst of derivatives expiry, global cues alongwith quarterly earnings of blue-chips such as Tata Motors, ITC, and Sun Pharma.

Reliance Industries' Mukesh Ambani tops Indian billionaire list in Forbes survey; see full list

Reliance Industries' Mukesh Ambani tops Indian billionaire list in Forbes survey; see full list

Tue, Mar 21, 2017

Reliance Industries' chairman and MD Mukesh Ambani has topped the list of Indian billionaires featured in Forbes recent survey titled 'The World's Billionaires' with global ranking of 33 and networth of $23.2 billion, find out names of other Indians in the list.

Lupin launches pain relief drug in US; shares rise

Lupin launches pain relief drug in US; shares rise

Thu, Mar 09, 2017

Drug firm Lupin today announced the launch of pain relief drug Hydrocodone Bitartrate and Acetaminophen in the US market.

NPPA reduces prices of essential drugs by more than 50% in March-Oct 2016

NPPA reduces prices of essential drugs by more than 50% in March-Oct 2016

Tue, Mar 07, 2017

NPPA on Tuesday tweeted list of 23 essential medicines under NLEM 2015 of which prices were reduced for more than 50% from March to October 2016.

Lupin's Q3 net profit rise by 21%; shares trade high

Lupin's Q3 net profit rise by 21%; shares trade high

Thu, Feb 09, 2017

Pharmaceutical-major Lupin on Thursday reported 21% rise in net profit during the quarter ended on December 31.

Lupin gets USFDA nod for hypertension treatment drug in US

Lupin gets USFDA nod for hypertension treatment drug in US

Mon, Dec 26, 2016

Drug major Lupin has received tentative approval from the US health regulator to sell Olmesartan medoximil tablets, used for treating high blood pressure, in the American market.

Top nine stocks you should buy this Diwali

Top nine stocks you should buy this Diwali

Sun, Oct 30, 2016

As India's biggest festival Diwali begins on Sunday, here are stocks that you could buy this festive season. According to BP Wealth's latest research report, here's the list of top nine stocks: 1. EID-Parry (India)

Lupin gets USFDA approval for generic Alzheimer treatment capsule

Lupin gets USFDA approval for generic Alzheimer treatment capsule

Thu, Sep 29, 2016

Pharma major Lupin on Thursday said it has received final approval from the US health regulator to market its memantine hydrochloride extended-release capsules, which are used in the treatment of the Alzheimer's disease.

Lupin shares fall 2% despite receiving approval for Acotiamide tablets

Lupin shares fall 2% despite receiving approval for Acotiamide tablets

Mon, Aug 22, 2016

Naresh Gupta, President, Lupin Limited said “We have a rich legacy of having introduced novel treatments to address unmet medical needs in the country. I am sure that the approval of Acotiamide would go a long way in addressing an otherwise common but unmet medical need for a safe and effective drug for the management of dyspepsia.”

Lupin shares fall despite 55% rise in Q1 net profit

Lupin shares fall despite 55% rise in Q1 net profit

Tue, Aug 09, 2016

Commenting on the results, Nilesh Gupta, Managing Director, Lupin Limited, said “This was a record quarter, driven by robust growth across all our key markets – the United States, India and Japan. We remain committed to maintaining our growth trajectory given new product launches and approvals driven by strategic investments in technology and research.”

Lupin to acquire 21 branded products from Japan's Shionogi

Lupin to acquire 21 branded products from Japan's Shionogi

Tue, Aug 02, 2016

Pharma company Lupin's Japanese subsidiary Kyowa Pharmaceutical Industry has entered into a strategic asset purchase agreement with Shionogi & Co., on August 1.

CCI slaps fine of nearly Rs 73 crore on Lupin; Stock down 0.76%

CCI slaps fine of nearly Rs 73 crore on Lupin; Stock down 0.76%

Tue, Aug 02, 2016

CCI has imposed monetary penalty of nearly Rs 73 crore on pharma company Lupin for allegedly refusing to supply drugs to M/s Maruti & Co., in Karnataka state on account of non-possession of NOC from Karnataka Chemists and Druggist Association (KCDA).

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x